There is 1 paper on P90RSK in aging research: 1 observational study in people.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: American Heart Association and others
- Humans1
Effects
2Atherosclerosis
upin mice1
1 study
Atherosclerosis
upin mice1
P90RSK increases atherosclerosis in mice (myeloid-specific dominant-negative p90RSK transgenic versus wild-type mice).
“the data obtained from our gain- or loss-of-function mice conclusively showed the crucial role of p90RSK in inducing senescent phenotype in macrophages and atherogenesis.”
Animalsmyeloid-specific dominant-negative p90RSK transgenic versus wild-type mice
Circulation
Cellular senescence
upin mice1
1 study
Cellular senescence
upin mice1
P90RSK increases cellular senescence in mice (myeloid-specific dominant-negative p90RSK transgenic versus wild-type mice).
“the data obtained from our gain- or loss-of-function mice conclusively showed the crucial role of p90RSK in inducing senescent phenotype in macrophages and atherogenesis.”
Animalsmyeloid-specific dominant-negative p90RSK transgenic versus wild-type micemacrophage
Circulation
Latest
Circulation
Senescent Phenotype Induced by p90RSK-NRF2 Signaling Sensitizes Monocytes and Macrophages to Oxidative Stress in HIV-Positive Individuals
Cross-sectional study in peopleMAPK/ERK signaling